Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery
NCT ID: NCT03718078
Last Updated: 2019-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2019-03-31
2020-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma
NCT06496113
Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function
NCT03766555
Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
NCT01768741
Real-time Navigation for Laparoscope Liver Resections Using Fusion 3D Imaging and Indocyanine Green Fluorescence Imaging
NCT03811704
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
NCT01392274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The strategy for colorectal cancer liver metastasis resection and liver cancer has evolved to a parenchymatic sparing procedure. This technic aims to minimize surgical margins width while removing the tumor. Therefore, the current standard for resection margins is a margin width superior to 1mm. However, there is still a debate concerning the margin width. Indeed, with modern chemotherapy, several studies reported no statistical differences in the overall survival between R0 patients and R1 patients treated with chemotherapy. However, in order to preserve patients from chemotherapy treatments' adverse effects an intra-operative microscopic assessment of surgical margins should be set up in order to reduce R1 margins occurrence.
Ex vivo study:
Surgical specimens obtained during hepatectomy will be imaged to generate an atlas of pCLE images.
In vivo study:
Intraoperative characterization of sub-capsular hepatic masses and surgical margins will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Confocal Laser Endomicroscopy
lt includes patients will undergo probe-based Confocal Laser Endomicroscopy during laparoscopic hepatic masses resection.
Confocal Laser Endomicroscopy
The study is divided in two parts. For the two parts, patients will receive an intravenous injection of indocyanine green:
1. Ex vivo study
\- Images/sequences of normal and abnormal hepatic tissues and surgical margins will be acquired on surgical specimens
2. In vivo study - Intra-operative pCLE imaging will be performed on hepatic masses and surgical margins
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Confocal Laser Endomicroscopy
The study is divided in two parts. For the two parts, patients will receive an intravenous injection of indocyanine green:
1. Ex vivo study
\- Images/sequences of normal and abnormal hepatic tissues and surgical margins will be acquired on surgical specimens
2. In vivo study - Intra-operative pCLE imaging will be performed on hepatic masses and surgical margins
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for a surgical resection of hepatic masses
* Provided signed informed consent
Exclusion Criteria
* Kidney failure
* Pregnancy or breastfeeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mauna Kea Technologies
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Mutualiste Montsouris
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
David Fuks, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02619-46
Identifier Type: OTHER
Identifier Source: secondary_id
MKT-2018-PERSEE-02-DIG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.